The anti-dyskinetic and the anti-parkinsonian effects of sub-anesthetic ketamine are also present in female preclinical models
Raveena Parmar, Mitchell J. Bartlett, Jasmine R. Meredith, Sansita Singh, Sydney Ragsdale, Scott J. Sherman, Torsten Falk
This study shows that sub-anesthetic ketamine reduces dyskinesia and improves motor function in female preclinical models of Parkinson's disease and L-DOPA-induced dyskinesia.
bioRxiv · Nov 3, 2026 · PreprintNeuroscience